| Title |
One-Year Evolution of Sleep Quality in Older Users of Benzodiazepines: A Longitudinal Cohort Study in Belgian Nursing Home Residents
|
|---|---|
| Published in |
Drugs & Aging, August 2014
|
| DOI | 10.1007/s40266-014-0203-3 |
| Pubmed ID | |
| Authors |
Jolyce Bourgeois, Monique M. Elseviers, Luc Van Bortel, Mirko Petrovic, Robert H. Vander Stichele |
| Abstract |
Chronic use of benzodiazepines and z-drugs (BZD/Zs), the most commonly used symptomatic treatment for sleep problems, is discouraged because of the unproven long-term effectiveness. In this study, we evaluated 1-year evolution of subjective sleep quality of chronic BZD/Z users compared with nonusers. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 2% |
| United States | 1 | 2% |
| Unknown | 59 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 11 | 18% |
| Student > Bachelor | 9 | 15% |
| Student > Ph. D. Student | 8 | 13% |
| Researcher | 4 | 7% |
| Other | 3 | 5% |
| Other | 8 | 13% |
| Unknown | 18 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 15 | 25% |
| Nursing and Health Professions | 10 | 16% |
| Psychology | 4 | 7% |
| Social Sciences | 4 | 7% |
| Neuroscience | 3 | 5% |
| Other | 5 | 8% |
| Unknown | 20 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 August 2014.
All research outputs
#19,280,634
of 23,866,543 outputs
Outputs from Drugs & Aging
#1,096
of 1,245 outputs
Outputs of similar age
#171,608
of 237,898 outputs
Outputs of similar age from Drugs & Aging
#9
of 11 outputs
Altmetric has tracked 23,866,543 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,245 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one is in the 4th percentile – i.e., 4% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 237,898 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.